(Total Views: 1058)
Posted On: 08/09/2018 10:45:02 AM
Post# of 182
SOHM, Inc. Subsidiary Daiichi Sankyo Group Files Its Acute Myeloid Leukemia (AML) Treatment Quizartinib in the US; the FDA Awarded Breakthrough Status for The Drug
https://www.nasdaq.com/press-release/sohm-inc...0809-00819
https://www.nasdaq.com/press-release/sohm-inc...0809-00819
(0)
(0)
Scroll down for more posts ▼
